Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China SXT Pharmaceuticals (SXTC) Intangibles (2018 - 2025)

China SXT Pharmaceuticals has reported Intangibles over the past 8 years, most recently at $8532.0 for Q3 2025.

  • For Q3 2025, Intangibles fell 46.33% year-over-year to $8532.0; the TTM value through Sep 2025 reached $8532.0, down 46.33%, while the annual FY2025 figure was $11808.0, 38.18% down from the prior year.
  • Intangibles for Q3 2025 was $8532.0 at China SXT Pharmaceuticals, down from $11808.0 in the prior quarter.
  • Over five years, Intangibles peaked at $85728.0 in Q1 2022 and troughed at $8532.0 in Q3 2025.
  • A 5-year average of $34747.4 and a median of $25191.0 in 2023 define the central range for Intangibles.
  • Biggest five-year swings in Intangibles: surged 65.72% in 2021 and later plummeted 67.49% in 2023.
  • Year by year, Intangibles stood at $42353.0 in 2021, then fell by 27.46% to $30724.0 in 2022, then fell by 26.72% to $22514.0 in 2023, then fell by 29.39% to $15898.0 in 2024, then plummeted by 46.33% to $8532.0 in 2025.
  • Business Quant data shows Intangibles for SXTC at $8532.0 in Q3 2025, $11808.0 in Q1 2025, and $15898.0 in Q3 2024.